Tizanidine
Ontralfy, Zanaflex
Skeletal Muscle Relaxant
NADAC/unit
$0.0308
No Shortage
Tier 1: 86.0%
18 Manufacturers
50 ANDAs
Tizanidine is indicated for the treatment of spasticity in adults.
vs. brand Ontralfy: Generic saves up to 100% per unit
Market Intelligence
2024-01-17 Class II Recall: Dr. Reddy's Laboratories, Inc.
2023-07-26 Class II Recall: Dr Reddy's Laboratories Limited
2023-07-12 Class II Recall: Preferred Pharmaceuticals, Inc.
2023-07-12 Class II Recall: Amerisource Health Services LLC
Generic Manufacturers
ALEMBIC PHARMACEUTICALS LTDALKEM LABORATORIES LTDAPOTEX INCAUROBINDO PHARMA LTDCADILA HEALTHCARE LTDCADILA PHARMACEUTICALS LTDDR REDDYS LABORATORIES INCEPIC PHARMA LLCFIDELITY BIOPHARMA CO USAINGENUS PHARMACEUTICALS LLCJUBILANT GENERICS LTDLEGACY PHARMA USA INCOXFORD PHARMACEUTICALS LLCRISING PHARMA HOLDING INCRISING PHARMA HOLDINGS INCRUBICON RESEARCH LTDSENORES PHARMACEUTICALS INCSUN PHARMACEUTICAL INDUSTRIES INCUNICHEM LABORATORIES LTDZYDUS PHARMACEUTICALS USA INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.